China on Friday said that price surge in medical products procured by Indian traders for COVID-19 management is due to prevailing demand-supply mismatch and market factors as they had to import raw materials to meet the excess demand from India. Chinese Foreign Ministry spokesperson Hua Chunying said that China agrees with India's envoy in Hong Kong Priyanka Chauhan calling for a stable and open supply chain, but she did not give any assurance on increasing the frequency of cargo flights to India to the level before the second wave. <br />''<br />''India's Consul General in Hong Kong earlier this week said that there has to be a sense of governmental level support and efforts from China to stop the price rise of medical products procured from China to India and restoration of cargo flights. Ms. Chauhan said, even if there is some supply-demand mismatch, there should be some sort of stability and predictability in product prices.<br />'' <br />''Responding to a question from Prasar Bharati Correspondent on this, Ms. Hua said that China has been encouraging its companies to meet India's procurement to meet the country's surge in coronavirus cases. She said, Indian side has also raised their demand through different channels, which has led to excessive demand in the market and driven up prices because the Chinese manufacturers have to import some of the raw materials from other countries. <br />''<br />''<span style="color: #222222;">About Indian envoy's call for increasing cargo flights, the Chinese spokesperson did not give a direct reply but expressed Beijing's commitment to keep the industrial supply chains open. Soaring prices of medical supplies like oxygen concentrators and disruption of cargo flights to India are slowing arrivals of medical goods, Ms. Chauhan said this week.</span><br />